About Next Sequence
Next Sequence is a venture capital firm founded in 2021. It is primarily based out of Paris, France. As of Dec 2024, Next Sequence has invested in 15 companies. It primarily invests in Series A round in France based startups. Its investments are spread across a wide range of sectors from High Tech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Series A round of Biomemory A lot of funds co-invest with Next Sequence, with names like Crédit Mutuel Innovation sharing a substantial percentage of its portfolio. Next Sequence has team of 13 people including 6 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A
Portfolio Soonicorns
Next Sequence's List of Top Investments
Next Sequence has a portfolio of 15 companies. Their most notable investments include Cradle and Biomemory.Their portfolio spans across United Kingdom, Canada, Argentina and 4 more locations. They have invested in High Tech, Enterprise Applications, Life Sciences and 6 other sectors, across stages such as Series A stage. Here is the list of top investments by Next Sequence:
1. Cradle
Provider of chemoproteomics solutions for protein design and development. The platform enables researchers to design proteins using predictive algorithms and AI design suggestions. It also offers 3D structure prediction, optimizing thermostability and codon expression.
Key facts about Cradle
- Founded Year: 2021
- Location: Zurich (Switzerland)
- Stage: Series B
- Total Funding till date: $103M
- Employee Count: 134 as on Aug 31, 2026
- Investors: Kindred Capital, IVP and 7 Others
- Latest Funding Round: Series B, Nov 26, 2024, $*****
- Highlight: Editors' Pick
2. Biomemory
Online platform offering bio-digital data storage solutions. The platform is developing a petrol-free DNA synthesis and copy process based on synthetic biology for data storage. It also allows the production of long, bio-sourced, biocompatible, and bio-secure DNA fragments that can be stored as inert polymers for thousands of years without any energy input.
Key facts about Biomemory
- Founded Year: 2021
- Location: Paris (France)
- Stage: Series A
- Total Funding till date: $23.2M
- Employee Count: 80 as on Sep 30, 2026
- Investors: Next Sequence, Groupe Prunay and 16 Others
- Latest Funding Round: Series A, Dec 10, 2024, $*****
- Highlight: Editors' Pick
3. Alora
Growers of salt-tolerant crops using ocean technology. It had developed patent-pending processes to restore salt tolerance to plant varieties. The technology targets plant genes to generate stem cells that are regenerated in labs and are further grown in ocean systems. The plants draw their nutrients directly from the saltwater around them.
Key facts about Alora
- Founded Year: 2005
- Location: Kitchener (Canada)
- Stage: Seed
- Total Funding till date: $1.65M
- Employee Count: 46 as on Sep 30, 2026
- Investors: Mistletoe, Toyota Ventures and 5 Others
- Latest Funding Round: Seed, Mar 03, 2026, $*****
4. Psylo
Developer of psychedelic derived therapeutic for mental illness. It provides psychedelics drugs that are improved treatments against selective serotonin reuptake inhibitors (SSRI) medications, allowing patients to recover from severe mental illness like treatment-resistant depression, anxiety, addiction, and others.
Key facts about Psylo
- Founded Year: 2021
- Location: Sydney (Australia)
- Stage: Seed
- Total Funding till date: $14.2M
- Employee Count: 10 - 49 as on Mar 01, 2026
- Investors: Palo Santo, Tenmile and 13 Others
- Latest Funding Round: Seed, Jun 03, 2024, $*****
- Highlight: Editors' Pick
Provider of AI downstream process optimization software for biotech industry. The company uses AI and computational modelling to help precision fermentation alt protein companies to optimise downstream processing.
Key facts about New Wave Biotech
- Founded Year: 2022
- Location: London (United Kingdom)
- Annual Revenue: £0 - £1M as on Dec 31, 2023
- Valuation: $*****
- Stage: Seed
- Total Funding till date: $1.32M
- Employee Count: 7 as on Sep 30, 2026
- Investors: Ukri, Next Sequence and 2 Others
- Latest Funding Round: Seed, Dec 19, 2024, $*****
- Highlight: Editors' Pick
Next Sequence's Year-on-Year Investment Trends
Its most recent first time investment was in Biomemory.Next Sequence's Investments by Stage
Next Sequence has made 1 investment in Series A stage with an average round size of $18M.Next Sequence's Investments by Sector
Next Sequence has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech and Life Sciences. Notably, it has invested in 12 Enterprise (B2B) companies, 12 Tech companies, 6 Software companies and at least 3 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 1 |
High Tech | 1 |
Life Sciences | 1 |
Note: We have considered here, only first round of investments
Next Sequence's Investments by Geography
Next Sequence has made most investments in France (1).Next Sequence's recent investments
Next Sequence has not made any investment in 2026 so far.Here are the most recent investments by Next Sequence:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 10, 2024 | France | Series A | 3535 |
Team profile of Next Sequence
Next Sequence has a team of 13 members including 6 Partners located in United States, United Kingdom and 2 more locations. Next Sequence's team does not sit on the board of any company as of now.Here is a list of top team members in Next Sequence:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | San Francisco | - | - | |
Partner | Austin | - | - | |
Partner | - | - | - | |
Partner | Sarajevo | - | - | |
Partner | London | - | - | |
Partner | Ireland | - | - |
Co-investors of Next Sequence
Over the past 2 years, 16 investors have co-invested in Next Sequence's portfolio companies. This includes funds and angels.
- Invested before Next Sequence: eureKARE, La French Tech and 7 others have invested in rounds before Next Sequence. There is 1 company where eureKARE has invested before Next Sequence and 1 company where La French Tech has invested before Next Sequence.
- Top Co-investors of Next Sequence: 7 investors entered a company along with Next Sequence. These include investors like Crédit Mutuel Innovation (1 company).
Recent News related to Next Sequence
•
•
Paris-based AQEMIA secures €94.9 million to expand to the UK and accelerates molecular researchEU-Startups•Dec 10, 2024•Aqemia, Cathay Innovation, Wendel, Bpifrance and 7 others
